高雄市生物科技發展協會|http://www.khba.org.tw
會員登入
記住帳號 自動登入
會員名錄
各式辦法
下載專區
留言板
您目前的位置:首頁 / 活動與新訊
Gut microbiome plays a role in immune response to mRNA COVID vaccines
活動日期:2024.01.23
2024.01.23  

Gut microbiome plays a role in immune response to mRNA COVID vaccines

https://reurl.cc/v0anlk

Jan 4 2024Karolinska Institutet

Researchers from Karolinska Institutet in Sweden have discovered that the gut microbiome can influence how well people respond to mRNA COVID vaccines. The study, published in the journal npj Biofilms and Microbiomes, suggests that certain bacteria in the gut can enhance the immune response to the vaccine, whereas other bacteria may weaken it.

The gut microbiome is the collection of microorganisms that live in our digestive tract. It plays an important role in many aspects of our health, such as digestion, metabolism, and immunity. The researchers wanted to find out if the gut microbiome also affects the response to mRNA COVID vaccines. To do this, the researchers collected stool samples from 68 people living with HIV and 75 healthy individuals before their first mRNA COVID vaccine dose.

The researchers analysed the microbiome composition using a technique called 16S rRNA sequencing, which identifies the types and relative abundance of bacteria in the samples. They also measured the levels of antibodies and immune cells that were produced after the vaccination.

We correlated the microbial composition with immune responses and patient characteristics. This comprehensive analysis included age, gender, body mass index and clinical factors for people living with HIV, aiming to understand the complex relationship between gut microbes and vaccine efficacy."

Piotr Nowak, principal investigator, senior physician and associate professor at Karolinska Institutet's Department of Medicine, Huddinge

The results showed that the initial makeup of the gut microbiome could predict the immune response to the vaccine in both groups. They found that a less diverse gut microbiome was associated with a stronger vaccine response, marked by higher levels of spike protein antibodies and spike specific CD4 T-cells. These are key components of the immune system that help to neutralize the virus and prevent severe infection.

The researchers also identified specific bacteria that were linked with better or worse vaccine responses. For example, they found that Lactobacillus, Bacteroides, and Lachnospira were associated with higher antibody and immune cell levels, while Cloacibacillus was associated with lower antibody levels. They also found that Bifidobacterium and Faecalibacterium were microbial markers of individuals with higher antibody levels.

Omics eBook Compilation of the top interviews, articles, and news in the last year.Download the latest edition

According to the researchers, the study highlights the significant role of the gut microbiome in the effectiveness of mRNA COVID vaccines. The findings could lead to developing microbiota-focused treatments to enhance vaccine responses, especially in groups that may have weaker responses, such as the elderly or immunocompromised individuals. The potential strategies could include changing the diet or taking probiotics to improve the gut microbiome and immunity, the researchers suggest.

The study was conducted in collaboration with the Karolinska University Hospital, and SciLifeLab National Genomics Infrastructure in Stockholm, Sweden. The research was funded by Region Stockholm, the Swedish Research Council, and Physicians Against AIDS.

Source:

Karolinska Institutet

Journal reference:

Ray, S., et al. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomesdoi.org/10.1038/s41522-023-00461-w.

共有314筆資料 頁數: 第15頁(共16頁)
編號 標題 新增日期
1 藥事論壇講座(第二十七屆)『生技/新藥研發最重要之科學新進展-.. 2008.02.12
2 吃喝玩樂中草藥達人 2008.01.18
3 藥事論壇講座(第二十六屆) 『藥物經濟與健保給付』 2008.01.17
4 財團法人生物技術開發中心研發成果發表暨97年度產學研合作說明會 2008.01.10
5 工研院 生醫研發成果及技術移轉說明會(高雄場次) 2007.12.04
6 生技新藥產業發展條例與施行辦法說明會 2007.12.03
7 2007醫藥生物科技新知研討會 2007.10.30
8 研討會:藥業經營之藍海策略與自費市場商機 2007.11.16
9 國立高雄大學生物科技研究所延攬兼任教師公告 2007.11.01
10 2007年高雄食品展覽會徵展通知 2007.07.23
11 2007年台北國際醫療器材、藥品暨生技展 2007.10.31
12 第二十五屆藥事論壇講座 - 生技新藥產業發展條例及其相關辦法 2007.10.20
13 國立高雄大學陳文輝教授主編全球首本蘭花生技專書 2007.10.18
14 生技產業趨勢研討會暨DCB南科據點成立茶會 2007.09.14
15 『生技創育∼區域優勢再創台灣農業生技新生命』座談會 2007.09.14
16 BioJapan2007-World Bussiness forum-Return Yokohama Again 2007.07.20
17 歐盟第七期研究架構計畫食物、農漁業和生物科技第一梯次徵求計畫 2007.08.13
18 中華兩岸關係發展促進會赴大陸武漢交流通知 2007.07.24
19 如何利用政府服務辦理國際行銷說明會 2007.08.07
20 加拿大CS Bio Co提供生肽Peptides產品 2007.08.14
上一頁  1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16  下一頁
版權所有©2006 高雄市生物科技發展協會 所有文字、資料禁止轉用
地址:高雄市中正一路120號14樓之3 TEL:(07)591-9569 / FAX:(07)591-9018 / e-mail: khba.tw@gmail.com
累積進站人數:3123277